Cargando…
Donor selection for adoptive cell therapy with CD45RA(−) memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release
BACKGROUND AIMS: We have previously demonstrated the safety and feasibility of adoptive cell therapy with CD45RA(−) memory T cells containing severe acute respiratory syndrome coronavirus 2–specific T cells for patients with coronavirus disease 2019 from an unvaccinated donor who was chosen based on...
Autores principales: | Al-Akioui-Sanz, Karima, Pascual-Miguel, Bárbara, Díaz-Almirón, Mariana, Mestre-Durán, Carmen, Navarro-Zapata, Alfonso, Clares-Villa, Laura, Martín-Cortázar, Carla, Vicario, José Luis, Moreno, Miguel Ángel, Balas, Antonio, De Paz, Raquel, Minguillón, Jordi, Pérez-Martínez, Antonio, Ferreras, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742221/ https://www.ncbi.nlm.nih.gov/pubmed/36585293 http://dx.doi.org/10.1016/j.jcyt.2022.12.001 |
Ejemplares similares
-
Cellular and Humoral Responses from Sars-Cov-2 Specific CD45RA- Memory T Cells from Convalescent and Naive Donors. Clinical Application As an Adoptive Cell Therapy for COVID-19
por: Sanz, Karima AL-Akioui, et al.
Publicado: (2022) -
Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19
por: Al-Akioui, K., et al.
Publicado: (2022) -
Familial CD45RA(–) T cells to treat severe refractory infections in immunocompromised patients
por: Al-Akioui Sanz, Karima, et al.
Publicado: (2023) -
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy
por: Ferreras, C., et al.
Publicado: (2021) -
Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells
por: Mestre-Durán, Carmen, et al.
Publicado: (2023)